Today's Daily Dose brings you news about the Complete Response Letter issued for Akcea; FDA approval of Tetrphase Pharma's XERAVA; Affimed's collaboration agreement with Genentech and Esperion's positive results from its phase 3 bempedoic acid/ ezetimibe combination pill study.
from RTT - Biotech https://ift.tt/2Nt4Rrf
via IFTTT
No comments:
Post a Comment